1.25 mg/ml solution for infusion

Active Pharmaceutical Ingredient: 

Pharmacotherapeutic group:
butyrophenone derivatives


  • Prevention and treatment of postoperative nausea and vomiting in adults as well as second-line treatment in children and adolescents (PONV).
  • Prevention of nausea and vomiting induced by morphine derivatives during postoperative patient-controlled analgesia (PCA) in adults.

Package size:
10 ampoules. Each ampoule of 1 ml of solution for injection contains 1.25 mg droperidol (1.25 mg/ml).